Presentation TCT 2018 COMPASS Trial Revisited: Weighing Rivaroxaban Secondary Prevention vs DAPT After PCI Presenter: Deepak L. Bhatt, Tullio Palmerini, Michael Maeng September 23, 2018
Presentation ESC 2018 Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk (MARINER) Trial: Primary Results Presenter: Alex C. Spyropoulos August 27, 2018